Immunology find could expand availability of hand, face transplantsScienceBlog.com (blog)Building on previous TBRC animal studies, the researchers tested whether combining bone marrow transplantation with VCA could induce chimerism and tolerance. In th…
Musharraf's heart like that of '18-year-old': Prosecutor – Times of India
Times of India |
Musharraf’s heart like that of ’18-year-old’: Prosecutor
Times of India ISLAMABAD: The condition of former Pakistani dictator Pervez Musharraf’s heart was today compared to that of an “18-year-old” by the government prosecutor to emphasize that he did not have any justification for skipping his treason trial. Prosecutor … |
Trevena doses first patient in TRV027 Phase 2b trial for acute heart failure – News-Medical.net
|
Trevena doses first patient in TRV027 Phase 2b trial for acute heart failure
News-Medical.net Trevena, Inc., a clinical stage pharmaceutical company involved in the discovery and development of G-protein coupled receptor (GPCR) biased ligands, announced today initiation of dosing in BLAST-AHF, the Company’s randomized, multi-center Phase 2b … Trevena Announces Dosing of First Patient in Phase 2b BLAST-AHF Trial of …Businessweek |
Mylan announces launch of Mycophenolic Acid Delayed-release Tablets – News-Medical.net
MarketWatch |
Mylan announces launch of Mycophenolic Acid Delayed-release Tablets
News-Medical.net Mylan Inc. (Nasdaq: MYL) today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Mycophenolic Acid Delayed-release Tablets, 180 mg and 360 mg. This product is the generic version of Novartis’ Myfortic® Delayed-release … Mylan Launches Generic Myfortic® Delayed-Release TabletsMarketWatch Mylan Launches Generic MyforticMonthly Prescribing Reference |
Changing the Face of Modern Medicine – Armed with Science
Armed with Science |
Changing the Face of Modern Medicine
Armed with Science Nearly a decade ago, the Defense Department began collaborating with civilian clinics to research and advance face transplant surgery to eventually help service members with devastating combat injuries from fighting in Iraq and Afghanistan. “We want to … |
Website to be launched on Jan 26 to promote organ donation – IBNLive
IBNLiveWebsite to be launched on Jan 26 to promote organ donationIBNLiveA website in English and Hindi would be launched from January 26 in Indore to promote organ transplantation and its donation after death. The bilingual website would make available…
Organ failure – South Wales Argus
|
Organ failure
South Wales Argus Organ failure. 12:05pm Thursday 9th January 2014 in Letters. WELL it seems that the Welsh Assembly’s decision to impose on us all in Wales the presumed consent of the organ donation law has been a dismal failure in getting Welsh people to accept it. |
Website for organ donation to bridge gap between donor and receivers – Times of India
The Globe and MailWebsite for organ donation to bridge gap between donor and receiversTimes of IndiaINDORE: A website for organ donation is in the offing to create awareness about organ donation and to bridge the gap between donor and receiver. The web…
Mylan Launches Generic Myfortic® Delayed-Release Tablets – MarketWatch
|
Mylan Launches Generic Myfortic® Delayed-Release Tablets
MarketWatch PITTSBURGH, Jan. 9, 2014 /PRNewswire via COMTEX/ — Mylan Inc. (NASDAQ:MYL) today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Mycophenolic Acid Delayed-release Tablets, 180 mg and 360 mg. This product is … Mylan Launches Generic Myfortic(R) Delayed-Release TabletsThe Providence Journal Mylan Launches Generic MyforticMonthly Prescribing Reference |
Zydus Cadila gets final approval for Sirolimus tablets with marketing exclusivity – pharmabiz.com
Zydus Cadila gets final approval for Sirolimus tablets with marketing exclusivitypharmabiz.comZydus Cadila has received the final US FDA approval to market Sirolimus tablets 0.5 mg with 180 days of marketing exclusivity. As per IMS data in 2013, the sa…